solifenacin

A muscarinic receptor antagonist drug used for treating contraction of overactive bladder such as incontinence, urinary frequency, and urgency. Solifenacin is a competitive cholinergic receptor antagonist, selective for the M3 receptor subtype. It was manufactured and marketed by Astellas, GlaxoSmithKline and Teva Pharmaceutical Industries. Reference standards of Solifenacin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => 2-[[(2-Ethylhexyl)oxy]methyl]oxirane-d5
    [catalogue_number] => PA STI 038010
    [category_ids] => ,84,98,
    [chemical_name] => 
    [weight] => 191.32
    [form] => C11H17D5O2
    [cas] => NA
    [pslug] => 2-2-ethylhexyl-oxy-methyl-oxirane-d5-pasti038010
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)